№ lp_1_2_04838
File format: docx
Character count: 58978
File size: 793 KB
This document outlines procedures for the safe and appropriate administration of Immunoglobulin (IVIg, SCIg, NHIg) within Canberra Health Services, including approval processes, clinical criteria, and guidelines for patient care.
Year:
2024
Region / city:
Canberra
Topic:
Immunology, Blood Products
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Nurses, Midwives, Students under direct supervision
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
V3.0
Author:
Dr Julia Sikorska, Consultant Haematologist, STSTN Clinical Guidelines Group
Note:
2019
Executive/Divisional sponsor:
Via Hospital Transfusion Committee
Applies to:
All staff involved in the care of patients with Sickle Cell Disease
Date issued:
V3.0 February 2020
Review date:
February 2023
Approval person/Committee:
Hospital Transfusion Committee
Date:
March 2020
Year:
2020
Region / city:
St George’s, UK
Topic:
Hyperhaemolysis management in Haemoglobinopathies
Document type:
Clinical guidelines
Organization / institution:
St George’s University Hospitals NHS
Target audience:
Healthcare staff involved in the care of Sickle Cell Disease patients
Effective period:
February 2020–February 2023
Approval date:
March 2020
Year:
2026
Region / City:
Australia
Theme:
Medical Travel, Blood Products, SCIg
Document Type:
Official Guidelines
Organization / Institution:
Australian Red Cross Lifeblood, National Blood Authority, Victorian Government Department of Health
Author:
Victorian Government, Department of Health
Target Audience:
Medical professionals, Patients requiring SCIg
Period of Validity:
Not specified
Date of Approval:
January 2026
Date of Last Update:
January 2026
Year:
2023
Country:
Australia
Document type:
Clinical guidance
Organization:
Australian Government Department of Health / Blood Service
Target audience:
Healthcare professionals administering IVIg
Scope:
IVIg administration, safety, and monitoring
Effective from:
April 2023
References:
Criteria for the clinical use of intravenous immunoglobulin in Australia, 3rd edition, October 2018; Product information sheets of Privigen®AU, Kiovig®, Flebogamma®, Gammunex®, Octagam®
Appendices:
Product comparison, infusion rate guides
Date:
March 2023
Country:
Australia
Subject:
Intravenous immunoglobulin administration
Document type:
Clinical practice guidance
Healthcare setting:
Hospital and health services
Target audience:
Healthcare professionals involved in IVIg prescribing and administration
Regulatory context:
BloodSTAR authorization and national IVIg criteria
Products referenced:
Privigen®, Kiovig®, Flebogamma®, Gammunex®, Octagam®, Intragam®10
Effective period:
From April 2023
Clinical scope:
Indications, precautions, preparation, infusion, storage, and adverse effects
Source type:
Official guidance
Year:
Not specified
Region / City:
Not specified
Subject:
Tetanus prevention, immunization, post-exposure prophylaxis
Document Type:
Medical guideline
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, medical practitioners
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2004-2016
Region / City:
Queensland, Australia
Topic:
Public health, immunoglobulin use
Document Type:
Research paper
Organization / Institution:
Griffith University, The Prince Charles Hospital, National Blood Authority
Author:
Megan K Young, Allan W Cripps, Graeme R Nimmo
Target Audience:
Public health professionals, researchers
Effective Period:
2004-2016
Approval Date:
N/A
Date of Revisions:
N/A
Year:
2026
Region / City:
United Kingdom
Subject:
Perinatal Hepatitis B Prevention
Document Type:
Medical Request Form
Institution:
NHS
Author:
Healthcare Practitioner
Target Audience:
Hospital staff and pharmacists
Period of Use:
Antenatal and postnatal period
Date of Issue:
2026
Instructions Included:
Yes
Emergency Procedures:
Yes
Vaccine Administration Guidelines:
Yes
Maternal Antiviral Treatment Recorded:
Yes
Infant Delivery and Health Data:
Yes
Form Submission Method:
Email
Year:
2026
Region / City:
United Kingdom
Topic:
Veterinary Immunology / Equine Asthma
Document Type:
Research Article
Institution:
University Veterinary Research Center
Authors:
[Not specified in document]
Target Audience:
Veterinary researchers, equine clinicians
Study Period:
Not explicitly stated
Sample Size:
12 horses (6 sEA-affected, 6 healthy controls)
Methodology:
Protein microarray-based IgE profiling
Key Findings:
Identification of novel allergens associated with severe equine asthma, reproducibility and specificity of microarray validated
Year:
2026
Region / City:
Western Australia
Subject:
Public Health, Rabies Immunoglobulin Supply
Document Type:
Guidelines, Information for Doctors
Organization:
Government of Western Australia, Department of Health
Author:
Department of Health, Public Health and Clinical Services, Communicable Disease Control Directorate
Target Audience:
Public Health Units, On-call Doctors
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Authors:
Brendan J. McMullan; Anita J. Campbell; Christopher C. Blyth; Jonathan C. McNeil; Christopher P. Montgomery; Steven Y. C. Tong; Asha C. Bowen
Type of document:
Narrative review article
Topic:
Pediatric Staphylococcus aureus bacteremia
Population:
Neonates, children and adolescents
Medical specialty:
Infectious Diseases
Methods:
Systematic appraisal of published literature
Data sources:
PubMed and Medline
Search period:
January 1960 – 31 December 2018
Geographic context:
High-income countries
Funding source:
No funding received
Conflict of interest:
None declared
Clinical scope:
Community-acquired and healthcare-associated bacteremia
Year:
2026
Organization:
Canberra Health Services
Department:
Neonatology
Document Type:
Procedure
Target Audience:
Medical Officers, Registered Nurses, Midwives, Student Nurses under supervision
Scope:
Neonates from birth to 44 weeks corrected gestational age
Related Policies:
Neonatal Intensive Care Drug Manual, ANMF guidelines
Definitions Included:
Blood Glucose Levels, Hyperglycaemia, Significant Hyperglycaemia
Treatment Recommendations:
Insulin infusion, glucose monitoring, TPN and enteral feeding guidance
Risks Addressed:
Hypoglycaemia, glucose delivery variability, insulin-plastic binding
Year:
2023
Region / City:
Canberra
Topic:
Healthcare Procedure
Document Type:
Procedure Manual
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Healthcare professionals (nurses, doctors, allied health staff)
Period of validity:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / city:
Canberra
Theme:
Medical Procedure
Document type:
Procedure
Organization:
Canberra Health Services
Author:
Unknown
Target audience:
Medical professionals, including Medical Officers, Nurses, and Midwives
Effective period:
Ongoing
Approval date:
Unknown
Date of amendments:
Unknown
Note:
Year
Topic:
Infection control, Acute Respiratory Infection
Document type:
Procedure
Organ / institution:
Canberra Health Services
Target audience:
Healthcare staff, students, trainees, and contracted agents working in CHS Network
Year:
2026
Region / city:
Canberra
Topic:
Clinical Procedures, Healthcare, Intravenous Access
Document Type:
Procedure
Organization / institution:
Canberra Health Services
Author:
Not specified
Target audience:
Healthcare professionals at Canberra Health Services
Effective period:
Ongoing
Approval date:
Not specified
Revision date:
Not specified
Year:
2023
Region / city:
Canberra
Topic:
Medical Procedure, Bleeding Disorders
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Author:
Canberra Health Services
Target Audience:
Medical and nursing staff involved in desmopressin administration
Period of validity:
Ongoing
Approval Date:
2023
Date of changes:
N/A
Note:
Year
Region / City:
Canberra
Subject:
Stoma care, Post-operative care
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Target Audience:
Healthcare professionals involved in stoma care
Description:
Procedure document for the management of patients with a stoma in Canberra Health Services, including pre-operative education, post-operative care, and various stoma-related issues across different patient groups.
Year:
2023
Region / city:
Canberra
Subject:
Neonatal respiratory support
Document type:
Clinical guideline
Author:
Canberra Health Services
Target audience:
Medical officers, nurses, midwives, physiotherapists, students under supervision
Date of approval:
Not specified
Date of changes:
Not specified
Clinical areas:
Neonatology, pediatric intensive care, respiratory therapy
Treatment procedures:
Invasive and non-invasive respiratory support, oxygen therapy, mechanical ventilation, physiotherapy
Medical equipment:
Ventilators, oxygen therapy devices, transcutaneous and end-tidal CO2 monitors, NAVA ventilators
Document type:
IRB review checklist
Subject:
Human subjects research involving non-viable neonates
Regulatory framework:
45 CFR §46.205
Intended users:
IRB members and Designated Reviewers
Review stages covered:
Initial review, continuing review, modifications, expedited review, convened IRB review
Responsible body:
Institutional Review Board (IRB)
Purpose:
Documentation of regulatory determinations and protocol-specific findings
Consent requirements:
Parental informed consent conditions
Record retention:
IRB protocol file